A rare cause of intestinal obstruction due to an exophytic gastrointestinal stromal tumor of the small bowel
1,Trakya Universitesi Hastanesi
2, Genel Cerrahi Anabilim Dali
3,Department of Medical Oncology Trakya University School of Medicine
4,Department of Pathology Trakya University School of Medicine
5,Department of Radiology Trakya University School of Medicine
DOI: 10.22514/SV42.102009.7 Vol.4,Issue 2,October 2009 pp.32-34
Published: 28 October 2009
Introduction: Gastrointestinal stromal tumors constitute a distinct group of rare gastrointestinal tract tumors that originate from the interstitial cells of Cajal. These jejunoileal lesions are a rare cause of obstruction but can be associated with substantial morbidity.
Case: A 59-year-old woman presented to the emergency department with abdominal pain and distention. Physical exami-nation revealed tenderness and rebound in right lower quadrant. Computed tomography revealed a mass in lower right quadrant. A 9x9x4 cm exophytic ileal mass was observed at exploration. Preoperative diagnose was a small bowel tumor and then segmental resection and primary anastomosis were performed. Histopathological investigation revealed spindle cells that stained strongly for C-117, consistent with a diagnosis of a malign gastrointestinal stromal tumor.
Conclusion: We conclude that exophytic small bowel gastrointestinal stromal tumors are rare lesions, which should be kept in mind by physicians among the diagnosis of small bowel obstructions in order to reduce substantial morbidity and mortality.
intestinal obstruction, gastrointestinal stromal tumor, small bowel, surgery
ATAKAN SEZER,MEHMET ALI YAGCI,AHMET RAHMI HATIPOGLU,IRFAN COSKUN,IRFAN CICIN,UFUK USTA,OSMAN TEMIZOZ. A rare cause of intestinal obstruction due to an exophytic gastrointestinal stromal tumor of the small bowel. Signa Vitae. 2009. 4(2);32-34.
1. Sunamak O, Karabicak I, Aydemir I, Aydogan F, Guler E, Cetinkaya S, et al. An intraluminal leiomyoma of the small intestine causing inva-gination and obstruction: a case report. Mt Sinai J Med 2006;73:1079-81.
2. Bucher P, Egger JF, Gervaz P, Ris F, Weintraub D, Villiger P, et al. An audit of surgical management of gastrointestinal stromal tumours (GIST). Eur J Surg Oncol 2006;32:310-4.
3. El Demellawy D, Shokry P, Ing A, Khalifa M. Polypoid gastrointestinal stromal tumor of small bowel metastasizing to mesenteric lymph nodes: a case report. Pathol Res Pract 2008;204:197-201.
4. Abbas M, Farouk Y, Nasr MM, Elsebae MM, Farag A, Akl MM, et al. Gastrointestinal stromal tumors (GISTs): clinical presentation, diagnosis, surgical treatment and its outcome. J Egypt Soc Parasitol 2008;38:883-94.
5. Beltran MA, Cruces KS. Primary tumors of jejunum and ileum as a cause of intestinal obstruction: a case control study. Int J Surg 2007;5:183-91.
6. Kimura H, Yoshida T, Kinoshita S, Takahashi I. Pedunculated giant gastrointestinal stromal tumor of the stomach showing extragastric growth: report of a case. Surg Today 2004;34:159-62.
7. Lupescu IG, Grasu M, Boros M, Gheorghe C, Ionescu M, Popescu I, et al. Gastrointestinal stromal tumors: retrospective analysis of the computer-tomographic aspects. J Gastrointestin Liver Dis 2007;16:147-51.
8. Spivach A, Zanconati F, Bonifacio Gori D, Pellegrino M, Sinconi A. Stromal tumors of the small intestine (GIST). Prognostic differences based on clinical, morphological and immunophenotypic features. Minerva Chir 1999;54:717-24.
9. Shah SN. Malignant gastrointestinal stromal tumor of intestine: a case report. Indian J Pathol Microbiol 2007;50:357-9.
10. Zanghi G, Di Stefano G, Strazzanti A, Benfatto G, Politi V, Basile F. Gastrointestinal stromal tumors: report of three cases and review of the literature. G Chir 2006;27:209-13.
Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,200 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.
Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.
Chemical Abstracts Service Source Index The CAS Source Index (CASSI) Search Tool is an online resource that can quickly identify or confirm journal titles and abbreviations for publications indexed by CAS since 1907, including serial and non-serial scientific and technical publications.
IndexCopernicus The Index Copernicus International (ICI) Journals database’s is an international indexation database of scientific journals. It covered international scientific journals which divided into general information, contents of individual issues, detailed bibliography (references) sections for every publication, as well as full texts of publications in the form of attached files (optional). For now, there are more than 58,000 scientific journals registered at ICI.
Geneva Foundation for Medical Education and Research The Geneva Foundation for Medical Education and Research (GFMER) is a non-profit organization established in 2002 and it works in close collaboration with the World Health Organization (WHO). The overall objectives of the Foundation are to promote and develop health education and research programs.
Scopus: CiteScore 0.5(2019) Scopus is Elsevier's abstract and citation database launched in 2004. Scopus covers nearly 36,377 titles (22,794 active titles and 13,583 Inactive titles) from approximately 11,678 publishers, of which 34,346 are peer-reviewed journals in top-level subject fields: life sciences, social sciences, physical sciences and health sciences.
Embase Embase (often styled EMBASE for Excerpta Medica dataBASE), produced by Elsevier, is a biomedical and pharmacological database of published literature designed to support information managers and pharmacovigilance in complying with the regulatory requirements of a licensed drug.